Motilal Oswal has buy call on Gland Pharma with a target price of Rs 2700. The current market price of Gland Pharma is Rs 2269.5.
Gland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 37108.47 Crore) operating in Pharmaceuticals sector.
Financials
For the quarter ended 31-12-2020, the company reported a Standalone Total Income of Rs 894.55 Crore. Company had reported net profit after tax of Rs 204.11 Crore in latest quarter.
Investment Rationale
Given that injectables have stringent regulatory guidelines compared with other dosages, GLAND is clearly at an advantage on account of its successful compliance. Moreover, it has delivered superior profitability / return ratios with minimal financial leverage.
